Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4lmc | C5P | Nucleoprotein |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
4lmc | C5P | Nucleoprotein | / | 1.000 | |
4kxj | P34 | Nucleoprotein | / | 0.657 | |
1ry8 | RUT | Aldo-keto reductase family 1 member C3 | / | 0.499 | |
4a95 | 9MT | Glycylpeptide N-tetradecanoyltransferase | / | 0.487 | |
4fcb | 0T7 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.487 | |
2a59 | LMZ | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.485 | |
1w76 | GNT | Acetylcholinesterase | 3.1.1.7 | 0.481 | |
2cf9 | 348 | Prothrombin | 3.4.21.5 | 0.480 | |
1ry0 | PG2 | Aldo-keto reductase family 1 member C3 | / | 0.478 | |
2xuj | TZ5 | Acetylcholinesterase | 3.1.1.7 | 0.476 | |
1i5r | HYC | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.467 | |
3zky | WT4 | Isopenicillin N synthase | 1.21.3.1 | 0.465 | |
4b13 | X25 | Glycylpeptide N-tetradecanoyltransferase | / | 0.464 | |
4bbh | YBN | Glycylpeptide N-tetradecanoyltransferase | / | 0.463 | |
4uy6 | SAH | Histidine N-alpha-methyltransferase | / | 0.463 | |
1xoq | ROF | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.462 | |
2cek | N8T | Acetylcholinesterase | 3.1.1.7 | 0.461 | |
1h22 | E10 | Acetylcholinesterase | 3.1.1.7 | 0.459 | |
2j3q | TFL | Acetylcholinesterase | 3.1.1.7 | 0.459 | |
3gsi | THG | Dimethylglycine oxidase | 1.5.3.10 | 0.458 | |
4drj | RAP | Serine/threonine-protein kinase mTOR | 2.7.11.1 | 0.457 | |
4drj | RAP | Peptidyl-prolyl cis-trans isomerase FKBP4 | 5.2.1.8 | 0.457 | |
1u65 | CP0 | Acetylcholinesterase | 3.1.1.7 | 0.456 | |
2f38 | 15M | Aldo-keto reductase family 1 member C3 | / | 0.456 | |
4e0u | 0MV | Cyclic dipeptide N-prenyltransferase | / | 0.456 | |
4ey7 | E20 | Acetylcholinesterase | 3.1.1.7 | 0.456 | |
4b4w | 9L9 | Bifunctional protein FolD | / | 0.455 | |
4n9q | FMN | FMN-dependent NADH-azoreductase 1 | / | 0.455 | |
1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.454 | |
4hf4 | 15H | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.454 | |
4kbz | 1QA | Egl nine homolog 1 | / | 0.454 | |
2xug | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.453 | |
3f3y | 4OA | Bile salt sulfotransferase | 2.8.2.14 | 0.453 | |
3g4i | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.453 | |
4a16 | H34 | Acetylcholinesterase | 3.1.1.7 | 0.453 | |
1udt | VIA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.451 | |
3kmy | D8Y | Beta-secretase 1 | 3.4.23.46 | 0.451 | |
4b11 | 7I1 | Glycylpeptide N-tetradecanoyltransferase | / | 0.451 | |
3zoi | M2W | Isopenicillin N synthase | 1.21.3.1 | 0.450 | |
4ddl | 0JQ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.450 | |
2cf8 | ESH | Prothrombin | 3.4.21.5 | 0.449 | |
3uzz | TES | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.449 | |
4fam | 0SZ | Aldo-keto reductase family 1 member C3 | / | 0.449 | |
1re0 | AFB | ADP-ribosylation factor 1 | / | 0.448 | |
1re0 | AFB | ARF guanine-nucleotide exchange factor 1 | / | 0.448 | |
2xuo | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.448 | |
3fkt | SII | Beta-secretase 1 | 3.4.23.46 | 0.448 | |
3g49 | 3G4 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.448 | |
3uzz | ASD | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.448 | |
4drh | RAP | Serine/threonine-protein kinase mTOR | 2.7.11.1 | 0.448 | |
4drh | RAP | Peptidyl-prolyl cis-trans isomerase FKBP5 | 5.2.1.8 | 0.448 | |
1fds | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.447 | |
2wu4 | HBP | Acetylcholinesterase | 3.1.1.7 | 0.447 | |
2xuq | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.447 | |
3pqb | VGP | Putative oxidoreductase | / | 0.447 | |
4bfw | ZVW | Pantothenate kinase | 2.7.1.33 | 0.447 | |
4f1l | 0RY | Poly [ADP-ribose] polymerase 14 | 2.4.2.30 | 0.447 | |
4jt8 | 1NR | NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 3.5.1 | 0.447 | |
4xzj | NAD | Putative NAD(+)--arginine ADP-ribosyltransferase Vis | 2.4.2.31 | 0.447 | |
2jf0 | HBP | Acetylcholinesterase | 3.1.1.7 | 0.446 | |
3tfu | PL8 | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase | 2.6.1.62 | 0.446 | |
3wav | DWV | Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | 3.1.4.39 | 0.446 | |
1c4u | IH1 | Prothrombin | 3.4.21.5 | 0.445 | |
1odc | A8B | Acetylcholinesterase | 3.1.1.7 | 0.444 | |
1wkh | PPE | [LysW]-aminoadipate semialdehyde transaminase | / | 0.444 | |
1zgc | A2E | Acetylcholinesterase | 3.1.1.7 | 0.444 | |
2ovv | PFH | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.444 | |
2xup | TZ5 | Acetylcholinesterase | 3.1.1.7 | 0.444 | |
2zhe | 13U | Prothrombin | 3.4.21.5 | 0.444 | |
4bfu | ZVU | Pantothenate kinase | 2.7.1.33 | 0.444 | |
1wkg | POI | [LysW]-aminoadipate semialdehyde transaminase | / | 0.443 | |
2pdm | ZST | Aldose reductase | 1.1.1.21 | 0.443 | |
4dbw | 511 | Aldo-keto reductase family 1 member C3 | / | 0.443 | |
4hcy | 0YN | Transketolase | / | 0.443 | |
1o6q | R17 | Squalene--hopene cyclase | 4.2.1.129 | 0.442 | |
1q0r | AKT | Aclacinomycin methylesterase RdmC | 3.1.1.95 | 0.442 | |
1r58 | AO5 | Methionine aminopeptidase 2 | / | 0.442 | |
1tkb | N1T | Transketolase 1 | 2.2.1.1 | 0.442 | |
2wo7 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.442 | |
3b8x | G4M | Putative pyridoxamine 5-phosphate-dependent dehydrase | / | 0.442 | |
3bur | TES | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.442 | |
1pj6 | FOL | Dimethylglycine oxidase | 1.5.3.10 | 0.441 | |
1ypm | RA4 | Prothrombin | 3.4.21.5 | 0.441 | |
2a57 | CRM | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.441 | |
2am2 | 2LG | UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase | / | 0.441 | |
2xuf | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.441 | |
4bfz | ZVZ | Pantothenate kinase | 2.7.1.33 | 0.441 | |
4g2l | 0WL | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.441 | |
2y04 | 68H | Beta-1 adrenergic receptor | / | 0.441 | |
4ami | G90 | Beta-1 adrenergic receptor | / | 0.441 | |
3pbl | ETQ | D(3) dopamine receptor | / | 0.441 | |
1fml | RTL | Retinol dehydratase | / | 0.440 | |
2ovy | PFJ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
2v3o | I26 | Prothrombin | 3.4.21.5 | 0.440 | |
3sfh | 1DI | Histone deacetylase 8 | 3.5.1.98 | 0.440 | |
3u5y | SCG | Raucaffricine-O-beta-D-glucosidase | 3.2.1.125 | 0.440 | |
4s0v | SUV | Orexin receptor type 2 | / | 0.440 |